An update from Cannara Biotech ( ($TSE:LOVE) ) is now available. Cannara Biotech has secured preliminary acceptance from the Société Québécoise du ...

Q2 2025 Management View CEO Yvonne L. Greenstreet stated, “Alnylam is firing on all cylinders, and we're swiftly establishing ourselves as a top-tier biotech company,” emphasizing the company’s focus ...

QuantiPath.bio, a biotechnology company redefining food safety through precision genetic diagnostics, today announced the ...

More than half of drug launches fall short of forecasts. Engaging payers during trial design and capturing outcomes with real ...

India's Bharat Biotech launches cell gene therapy facility, eyes product launch by 2028 By Rishika Sadam March 20, 20258:17 AM PDTUpdated March 20, 2025 ...

The latest biotech industry updates! Featuring new partners for the 1000 Genomes Long Read Project and iPSC-derived human ...

After 10 years of development, the company is working to go to market with a gel patch to repair perforated eardrums.

Ryoncil® planned for launch this quarter once Company receives National Drug Codes (NDC) from FDA, enabling subsequent publication of product pricing in the U.S. Price Compendia.

Eva Keck is Vice President at PharmaLex. She has more than 20 years of experience in the pharmaceutical and biotechnology industry. Eva has worked at all levels – from operational product ...